Your browser doesn't support javascript.
loading
The impact of donor/recipient age difference and HLA mismatch on graft outcome in pediatric kidney transplantation.
Trnka, Peter; McTaggart, Steven J; Francis, Anna.
Afiliação
  • Trnka P; Child and Adolescent Renal Service, Children's Health Queensland, South Brisbane, Australia.
  • McTaggart SJ; School of Medicine, University of Queensland, Brisbane, Australia.
  • Francis A; Child and Adolescent Renal Service, Children's Health Queensland, South Brisbane, Australia.
Pediatr Transplant ; 22(7): e13265, 2018 11.
Article em En | MEDLINE | ID: mdl-29992708
ABSTRACT

BACKGROUND:

Understanding the relationship between the factors that influence long-term kidney transplant survival remains a key priority for pediatric nephrologists. We assessed the relative impact of donor/recipient age difference and HLA matching on long-term graft outcomes.

METHODS:

We conducted a retrospective cohort study of pediatric and adolescent recipients who received a primary kidney transplant in Australia and New Zealand between January 1, 1990, and December 31, 2015. The primary outcome was graft survival analyzed by Kaplan-Meier method.

RESULTS:

During the 26-year period, 1134 primary (395 DD and 739 LD) kidney transplants were performed in recipients less than 20 years of age. The median follow-up time was 10.2 years. Overall, 405 patients (35.7%) lost their transplant with graft survival 93.8% at 1 year, 82.5% at 5 years, 65.8% at 10 years, and 49.9% at 15 years post-transplant. There was consistently higher graft loss of DD kidneys as compared to LD kidneys at each time point. Both increasing donor/recipient age difference (aHR 1.11 per 10 years; 95% CI, 1.02-1.20; P = 0.009) and increasing HLA mismatch (aHR 1.20 per mismatch; 95% CI, 1.10-1.30; P < 0.001) were associated with decreased graft survival.

CONCLUSIONS:

Donor/recipient age difference and HLA matching are important factors influencing long-term graft outcomes in pediatric kidney transplantation. HLA mismatch remains a strong predictor of graft loss. For patients without the option of a LD, we suggest that the degree of HLA mismatch should not be discounted as part of the decision-making process of organ allocation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Sobrevivência de Enxerto Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Sobrevivência de Enxerto Idioma: En Ano de publicação: 2018 Tipo de documento: Article